Mytrex Health Technologies, Inc. (TPEX:4431)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
17.60
0.00 (0.00%)
Jul 30, 2026, 1:49 PM CST

TPEX:4431 Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,9451,9451,7591,2931,472291.62
Revenue Growth
1.78%10.59%36.02%-12.14%404.61%-71.51%
Gross Profit
242.58242.58221.55192.35239.440.14
Operating Income
-25.27-25.27-77.63-71.83-46.74-15.46
Net Income
-16.6-16.6-82.38-56.22-91.9-14.01
Earnings Per Share
-0.45-0.45-2.25-1.54-2.52-0.38
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Medicine Distribution Division
1,7651,7651,5931,113--
Technological Material Business Segment
129.71129.71109.8134.77192.23260.47
Medical Biotechnology Business Sector (Including Medical Sanitation Materials)
49.7749.7753.3341.2342.5840.38
Other Department
0.010.012.984.33-0.64
Adjustment and Elimination
-0.02-0.02-0.03--1.73-9.19
Total
1,9451,9451,7591,2931,472292.29

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
421.63421.63277.52240.75486.53471.21
Total Debt
163.07163.07224.44250.67208.8354.51
Net Cash (Debt)
258.56258.5653.09-9.93277.7416.7
Net Cash Growth
246.12%387.05%---33.36%-30.00%
Net Cash Per Share
7.087.081.45-0.277.6011.41

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
200.5200.531.63-4.2672.4813.29
Capital Expenditures
-4.33-4.33-8.88-21.77-35.5-29.75
Free Cash Flow
196.17196.1722.75-26.0336.98-16.46
Free Cash Flow Growth
-762.17%----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
12.47%12.47%12.60%14.88%16.27%13.76%
Operating Margin
-1.30%-1.30%-4.41%-5.56%-3.18%-5.30%
Pretax Margin
-1.11%-1.11%-4.79%-4.42%-4.20%-4.66%
Profit Margin
-0.85%-0.85%-4.68%-4.35%-6.25%-4.80%
FCF Margin
10.09%10.09%1.29%-2.01%2.51%-5.64%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
3.413.2240.30-25.00-
PS Ratio
0.340.330.520.880.633.44